chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information was received on 23-OCT-2017 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) subcutaneous on or about 20-DEC-2013, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 11-OCT-2016, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. The patient has been prescribed valacyclovir hydrochloride (VALTREX) for management of his persistent and painful symptoms. The patient experiences chronic neuralgia and permanent nerve pain secondary to his shingles infections. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Chronic neuralgia and permanent nerve pain was considered to be disabling. Additional information has been requested.
Extreme fatigue, had trouble getting out of bed and needed help. Slept most of the 24 hours after the adverse even started. Diarrhea upon getting up and lasted approximately 6 hours. Soreness in left arm.
Received HPV on 10/10/2016 - returned to office on 10.31.16: Child threw up once on 10/18 at school, had blood in it. His stool on that day had blood in it as well, per child. No more symptoms until he threw up a small amount while in the shower once last week. Per child, he did see some blood in it again. Has no more vomiting since then, has a good appetite with no abdominal pain. Child does not get a bm every day but every 4-5 days, denies having hard stools. MIRALAX recommended and ordered Stool Occult test - no specimen was ever received by parent/patient. Seen on 2.21.17: Frontal headache off and on for few months. Happens at any time of the day, no vomiting but does c/o blurred vision with headache. Usually takes a nap and it helps some. Has not been taking any medication for pain regularly. He does c/o stomachache off and on, no vomiting. Appetite is fine. Referred to Neurologist. Seen on 7.7.17: His symptoms started after getting HPV, per mom. Has had vaccines on 10/10/2016, started spitting up blood once a week after that. Seen in the office on 10/30/16. Symptoms resolved but then he started c/o headaches and blurred vision off and on, seen in the office on 10/31/2016. Child referred to Neurologist for further management. Has seen Dr. twice, prescribed iron supplement and amitriptyline for migraine headache. His iron was normal at his 12 year old Physical. Mom is concerned about HPV reaction as the child developed all these symptoms after getting shot on 10/10/2016. Has a followup appointment with Neurologist on 7/11. He constantly c/o being cold, stays in warm room constantly. Mom is really concerned. Mom is really concerned about HPV reaction as child developed symptoms after that visit. Will file Vaccine Adverse Reaction report. Mom notified.  Ordering TSH and Free T4 due to sensation of feeling cold.
Information has been received via literature article regarding a case in litigation concerning a now 54 year old female with common variable immunodeficiency disorder (CVID) and a 30 years earlier history, given by her to a gastroenterologist, of chronic uncontrolled diarrhea from spastic colon, who on 07-MAR-2001 was vaccinated with a dose of VARIVAX (Merck) in connection with a clinical research study.  Concomitant medication was not reported.  The patient experienced aggravating of her common variable immunodeficiency disorder after receiving VARIVAX (Merck) and the patient hypothesized that VARIVAX (Merck) aggravated her condition.  However a preponderance of the evidence does not support the existence of a preexisting immunologist disorder, CVID, prior to immunizations.  The reporter stated the patient's theory must fail since the vaccine could not aggravate that which was not proven to exist.  Follow up information was received via literature article regarding a case in litigation which reported that the patient was in regular contact with study staff who were following a protocol for collecting information about vaccine side-effects, and there was no contemporaneous record of the symptoms that the patient reports.  The judge said "she also was in regular contact with the primary physician, and had other medical treatments in 2001, yet non of the contemporaneous records before the chief special master mentioned the severe post-vaccination symptoms that are now alleged by the patient to have occurred in 2001".  This is a consolidation of two reports concerning the same patient.  Additional information has been requested.
Mother c/o fever - 101 degrees - 102 degrees profuse vomiting of all formula ingested beginning on 3/4/13. Late AM of 3/5/13 fever down to 99 degrees, pt still vomiting all formula. Symptoms did not begin until after pt. received immunizations.
Information has been received from a physician concerning a patient who was vaccinated PO with the first dose of ROTATEQ. The physician reported that the patient subsequently developed abdominal cramping. The patient was taken to the Emergency Room (ER), but it was not known if the patient was hospitalized. The ER physician stated he "believed this to be a case of intussusception, but made no concrete diagnosis." The patient's symptoms improved and the patient was removed from receiving further doses of ROTATEQ. The reporting physician noted that he only saw the patient after the adverse reaction occurred but the patient was not seeing him prior to the adverse reaction. No further information was provided. Additional information has been requested.
Covid arm- redness about the size of a large egg, heat to the touch and itchy  Lasted about 2 days
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was reported No treatment information was provided   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Severe headache 2-3d after vaccine and erythema, swelling, tenderness at left leg injection site.
Hospital Course:    Patient is a 43 y.o. female patient who originally presented to the hospital on 1/3/2021 due to  Left lower extremity pain and swelling.  Patient found to have extensive DVT of left lower extremity and started on heparin drip.  Vascular was consulted and recommended thrombolysis.  Patient was also seen by IR who took patient for thrombectomy and left iliac stent placement on 01/05/2021.  Patient tolerated procedure well.  Patient was transitioned from heparin drip to Eliquis upon discharge.  Patient given vascular follow-up as well as Hematology follow-up.
Received PPS 23 and flu vaccine on 10/16/17. Patient called 10/19/17 and reported left arm swollen, including armpit, up to shoulders, down to elbow. She also states lymph nodes are swollen. Pain 5/10. Hot to the touch, red. Background: Patient is on long-term steroids, has RA. Assessment: Large extent of redness and swelling. Recommendation: Advised patient to go to ED for assessment. Patient went to  ED- diagnosed with cellulitis. Was prescribed AUGMENTIN and BACTRIM. Patient was called on 10/23/17 and said she felt much better.
Injection site-Erythematous-indurated 3x4 inches and painful. Ipsilateral axilla swollen and tender, with anterior axillary fold swollen. Pt describes numbness and tingling in axilla and right anterior chest wall.
pt recv vax 22FEB96 & 23FEB96 pt devel urticaria;since that time pt cont to exp weekly acute flare-ups of urticaria which lasted 2 to 3 days;MD noted there were no discernible triggers to urticaria flare ups;
Patient received two vaccinations (the new Covid booster and Flu) in the same arm (Left). After about 5 minutes receiving the vaccines, patient started losing color in his face and slumping over in his chair; his jaw started clinching and wasn't responding to the pharmacist's and spouse's questions. Patient has had history of passing out due to needlesticks before and was watching his spouse receive both vaccines when this happened. 911 was contacted instantly. We brought patient to floor safely and laid out flat, in case we had to start chest compressions. Once laid out, patient started regaining consciousness and answering questions. EMS arrived shortly after and ran some tests. Patient left without having to go to the hospital after clearing their tests.
Just over a week after injection, experienced itchiness, swelling, redness at site of injection (right arm).
the patient had titers drawn and was negative for varicella and measles immunity; the patient had titers drawn and was negative for varicella and measles immunity; This spontaneous report was received from a nurse prescriber referring to a 15 years old male patient. Information about pertinent medical history, drug reaction/allergy and concomitant medication was unknown.  On 10-MAR-2005, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (1 dosage form; therapy type strength, route of administration, lot# and expiration date were not reported) and the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (1 dosage form; strength, route of administration, lot# and expiration date were not reported) for prophylaxis.  On 27-MAR-2008, the patient was vaccinated with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (1 dosage form; therapy type, strength, route of administration, lot# and expiration date were not reported) for prophylaxis. On 29-APR-2008, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (1 dosage form; strength, route of administration, lot# and expiration date were not reported) for prophylaxis.    On 06-NOV-2019, the patient had titers drawn and showed negative for varicella and measles immunity. The patient sought physician's medical attention and on 30-NOV-2019, the patient's pediatrician administered one dose of PROQUAD to the patient. It was unknown if lab diagnostics was performed or not. The outcome of the events was unknown. The causality between the events and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), varicella virus vaccine live (oka/merck) (VARIVAX) was not provided.
Swelling, red rash on face, especially cheeks, starting about 7 days after both the first and second vaccine doses. Red rash on left had at index finger knuckle.
red ring around the injection site; soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red ring around the injection site) and VACCINATION SITE PAIN (soreness around the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced RASH ERYTHEMATOUS (red ring around the injection site) and VACCINATION SITE PAIN (soreness around the injection site). At the time of the report, RASH ERYTHEMATOUS (red ring around the injection site) and VACCINATION SITE PAIN (soreness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medications were not provided by reporter.
Right deltoid extensive swelling, tender, warm, erythermatris, lymphoid streaking toward pictural region. Tx: Prednizone 40mg  tape 10mg no 3D, Augemntin 875 mg  BID x 7 days.
I received the Pneumococcal vaccine and the Influenza vaccine in my rt. deltoid at approx. 0815 Monday, 11/5/07. That evening I felt feverish, weak, fatigued, the rt. axillary hurt and the lymph nodes in the throat and neck hurt.  The rt. arm appeared swollen as well as the rt. axillary.  The rt. arm, wrist and hand ached and was swelling to the point that a fist could not be made.  By the next morning, I could hardly move my arm and it was painful under the rt. arm and the rt. deltoid.  I had a fever of 100.3, and the rt. hand was ice cold all day.  On Wed. 11/7/07, still running a fever, saw the doctor due to some red raised welts that were appearing on the arm.  I was told to return in two days if it did not get better.  On 11/8/07 the red raised areas are larger and spreading.  There is more movement in the arm, but it is still very painful.  Still have a headache, some dizziness, body aches and feel very tired.
Patient lied on form stated she was 16 when she wasn't - intern pharmacist administered vaccine but DOB wasn't confirmed until later with passport dob. Patient is aware she is ineligible for further dose until approval
After the first dose, almost at 3 weeks I began to feel mild itching between my fingers, between the joints. behind the ears, behind the head, on the feet and knees.; This is a spontaneous report from a contactable consumer. A 56-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 1, single on an unspecified date (at the age of 56-year-old) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received both doses of the Pfizer Covid 19 vaccine, and he received the second dose on 28Apr2021. After the first dose, almost at 3 weeks patient began to feel mild itching between fingers, between the joints. behind the ears, behind the head, on the feet and knees on unspecified date. Not everywhere at the same time. Before the second dose, on 22Apr2021 patient had surgery on one of the fingers in his left hand, at first, he thought the anesthesia had caused him the allergy. After receiving the second dose patient still felt itchy, but this time the itching was a little stronger. Consumer went to the doctor, to the ER and they gave him the allergy medication, but it didn't work for him. Patient still had the itching and if he gets hit anywhere on the body, instead of feeling pain, he felt itching. Patient's wife also received both doses of the vaccine and she had a rash between her fingers and itching at the top of her hand. Consumer asked was this serious and will it go away. Therapeutic measures were taken as a result of event. At the time of this report, the outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sour tongue; sour taste in my mouth 24 hours a day; Diarrhea like symptoms; Tiredness; Occasional tingling in my fingertips; Mouth irritation; This is a spontaneous report form a contactable consumer. This 80-year-old male patient reported for himself stating that he received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6205) via an unspecified route of administration into the left arm on 11Mar2021 14:00 (at the age of 80-year-old) as single dose for COVID-19 immunisation. The patient medical history was not reported. Have a surgery but have seem to get a clean health, thinks that all was good. He has no other health problems really, nothing other the old age, no problems. Concomitant medication included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, start and stop dates were not reported, takes one of them every day. The patient previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9266) via an unspecified route of administration into the left arm on 18Feb2021 16:00 (at the age of 80-year-old) as single dose for COVID-19 immunisation. On 11Mar2021, the patient experienced mouth irritation. On an unspecified date, he experienced sour tongue; sour taste in his mouth 24 hours a day, diarrhoea like symptoms, tiredness and occasional tingling in his fingertips. The patient underwent lab tests which showed magnetic resonance imaging on 10Jun2021 and positron emission tomogram on 15Jun2021, both as negative, they could not find any cancer, correct. He spoke to several doctors since his changes of taste were occurring and had constant mouth irritation, sour tongue since, third week from his first COVID shot. Did not know how to describe it but it was a sour taste in his mouth 24 hours a day and it seems to he does not know what else to say about it expect talked to doctor several times and couples of other specialists that he has been seeing and they think it possible that it could be linked to the COVID shot since it was the sourness that he feels in his mouth was one of the symptoms of COVID. He had a couple of other side effects but few weeks ago they went away, for about a month from that day he was going to call loose bowels, not terrible but diarrhoea like symptoms and they lasted probably 3 weeks. Had tiredness that he experienced and was not experiencing now. Seemed to be quite good about that and occasional tingling in his fingertips but that seems to be helped, it was almost gone but once in a while. Those all sort occurred at same time but the sour taste in his mouth and tongue was constant or just do not go away. No other medical conditions. Treatment for event included that he went to doctor several times and he just suggested nothing to do about it.no prior vaccination. He was thrilled that he was able to get through there that day. Outcome was not resolved for event sour tongue; sour taste in my mouth 24 hours a day and was unknown for rest of the events.
BILATERALLY RASH ON LOWER EXT 4 DAYS POST VACCINATION, CONTINUED THRU TODAY. NO PAIN OR ITCHING ASSOCIATED WITH RASH, NORMAL SKIN TEMPERATURE. NO C/O DIB, SOB, OR CHEST PAIN.
Within 10 minutes or less of receiving vaccination, experienced dizziness, extremely dry mouth with strong metabolic taste, heaviness of extremities and felling of "puffy" upper lip but this was not visibly observed. Symptoms subsided in order they appeared. Totally the symptoms lasted 1 24hours. Experienced extremely sore muscles for 2 weeks.
Diarrhea; Stomach ache; This is a spontaneous report from a contactable consumer. An 85-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: L5318; expiration date not provided), via an unspecified route of administration (anatomical location: left arm) on an unspecified date at SINGLE DOSE for COVID-19 immunisation. Patient has no medical history. Patient has no prior vaccination within 4 weeks and no AEs following prior vaccinations. There were no concomitant medications. The patient experienced diarrhea and stomach ache on 01Feb2021. Patient's clinical course is as follows: It was reported that reporter is a caretaker of the patient and mentioned that they both had the shot today (unspecified date). The reporter has taken the patient's temperature a couple times, the last time it was 98.6 (unit not specified). Reporter mentioned that patient was experiencing runny diarrhea and wants to know what to do about this. It was also reported that after getting the shot, around 12:30 (unspecified date), the patient started having the diarrhea. Patient also reported stomach ache that started around the same time. Patient never had diarrhea this long and like this before. It was reported that second dose is due on 22Feb2021. The patient underwent lab tests and procedures which included body temperature: 98.6. Outcome of the events was not recovered.
Fatigued, nauseous, severe persistent headache for four and a half days (ibuprofen and Excedrin only minimize the headache), dizziness, muscle weakness. Symptoms still strong after 4 days vaccine was given.
Left side of my face feels numb; Left side of my face feels weird; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Left side of my face feels numb) and FEELING ABNORMAL (Left side of my face feels weird) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HYPOAESTHESIA (Left side of my face feels numb) and FEELING ABNORMAL (Left side of my face feels weird). At the time of the report, HYPOAESTHESIA (Left side of my face feels numb) and FEELING ABNORMAL (Left side of my face feels weird) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 23-MAR-2018, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 injection, lot # N025563, expiration date 08-APR-2019 (exact dose and route of administration were not reported). On an unknown date, the vaccine experienced a temperature excursion from 47 F to 77 F for 48 hours. There was no previous temperature excursion reported. The temperature excursion did not occur as a result of reading from digital data logger. No adverse effects were reported. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1804USA007262: